GSK endows research chair at Univ of Manitoba

GlaxoSmithKline (GSK) is contributing $1 million to the Univ of Manitoba to establish an endowment for a research chair in the immunobiology of infectious disease. The funds will be used to establish the chair and recruit a top researcher as chairholder. The GSK endowment is part of the company's $22-million initiative — Pathfinders Fund for Leaders in Canadian Health Science Research. Previous contributions from the fund include $1.75 million to the Univ of Alberta (virology) and $1.25 million for the Univ of Calgary (inflammatory lung disease)....